Israel Chemicals (NYSE:ICL) Issues Earnings Results, Beats Expectations By $0.01 EPS

Share on StockTwits

Israel Chemicals (NYSE:ICL) announced its quarterly earnings data on Thursday. The basic materials company reported $0.10 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $0.09 by $0.01, Briefing.com reports. Israel Chemicals had a return on equity of 14.03% and a net margin of 9.04%. The business had revenue of $1.33 billion for the quarter, compared to analysts’ expectations of $1.33 billion. During the same period in the previous year, the business posted $0.10 EPS. The firm’s quarterly revenue was down 3.4% compared to the same quarter last year.

Shares of ICL traded up $0.04 during midday trading on Friday, hitting $4.60. 109,167 shares of the company traded hands, compared to its average volume of 158,197. The stock has a 50-day moving average of $4.68 and a 200-day moving average of $5.02. Israel Chemicals has a one year low of $4.36 and a one year high of $6.48. The firm has a market cap of $5.94 billion, a P/E ratio of 12.43, a PEG ratio of 1.19 and a beta of 0.89. The company has a debt-to-equity ratio of 0.53, a current ratio of 1.51 and a quick ratio of 0.85.

Separately, Zacks Investment Research upgraded Israel Chemicals from a “sell” rating to a “hold” rating in a research note on Tuesday, October 29th.

Israel Chemicals Company Profile

Israel Chemicals Ltd. operates as a specialty minerals and chemicals company worldwide. It operates in four segments: Industrial Products, Potash, Phosphate Solutions, and Innovative Ag Solutions (IAS). The Industrial Products segment produces bromine out of a solution that is a by-product of the potash production process, as well as bromine-based compounds; produces various grades of potash, salt, magnesium chloride, and magnesia products; and produces and markets phosphorous-based flame retardants and other phosphorus-based products.

Featured Story: Cost of Equity For A Business, Investors

Earnings History for Israel Chemicals (NYSE:ICL)

Receive News & Ratings for Israel Chemicals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Israel Chemicals and related companies with MarketBeat.com's FREE daily email newsletter.

 


Latest News

Yu Darvish Receives Cortisone Shot for Elbow Impingement
Yu Darvish Receives Cortisone Shot for Elbow Impingement
Red Sox and Brandon Phillips Agree to Minor League Deal
Red Sox and Brandon Phillips Agree to Minor League Deal
Chris Sale Proves He is 2018 AL Cy Young Candidate
Chris Sale Proves He is 2018 AL Cy Young Candidate
Strong Results by Clint Frazier Could Keep Him with Yankees
Strong Results by Clint Frazier Could Keep Him with Yankees
Giants Closer Breaks Hand Punching Door Following Poor Outing
Giants Closer Breaks Hand Punching Door Following Poor Outing
Evan Longoria Out Six to Eight Weeks With Broken Hand
Evan Longoria Out Six to Eight Weeks With Broken Hand


 
© 2006-2019 BBNS.